RECOVERY & PERFORMANCE MEDICINE

Chronic Pain & Fatigue Recovery

Stem Cell Therapy for Chronic Pain & Fatigue

Stem cell therapy for chronic pain and fatigue at Healthi Life Bangkok is an investigational, non-surgical regenerative protocol — a physician-set therapeutic dose of 50 million fresh mesenchymal stem cells delivered by IV infusion, physician-led. Pricing is confirmed after a physician consultation. Investigational; outcomes vary.

3–5 Day Physician-Led Protocol · Starting from THB 559,000 (~$18,000 USD)

50 Million Fresh MSCs
GMP & ISO Certified Partner Labs
3–5 Day Protocol

A Regenerative Approach to Chronic Conditions

What Is Chronic Pain Stem Cell Therapy?

Chronic Pain Stem Cell Therapy is a physician-led regenerative protocol designed for individuals suffering from persistent pain, fatigue, and inflammatory conditions that have not responded to conventional treatments.

Using 50 million fresh mesenchymal stem cells, this physician-led protocol is studied for its potential to calm systemic inflammation and support immune balance and tissue recovery; it is investigational and individual outcomes vary.

The protocol is studied in the context of persistent pain, long-standing fatigue, and inflammation-related conditions; it is investigational and outcomes vary.

Investment

Programs starting from THB 559,000 (~$18,000 USD). Final protocol determined after medical consultation.

Chronic Pain Stem Cell Therapy clinic at Healthi Life Bangkok

50M

Fresh MSCs

Targeted Regenerative Benefits

Key Benefits

Inflammation Support

Studied for its potential to calm systemic inflammation at the cellular level; outcomes vary.

Immune Rebalancing

Studied for a potential role in rebalancing dysfunctional immune pathways; responses vary.

Long-Term Tissue Support

Studied for its potential to support tissue repair over months; outcomes vary.

Day-to-Day Comfort

Some guests report improved day-to-day comfort; responses vary and no neurological effect is claimed.

Energy Support

Studied for a potential role in supporting mitochondrial function and reducing fatigue; outcomes vary.

Functional Support

May support daily mobility, sleep quality, and overall quality of life; outcomes vary.

Your Treatment Journey

3–5 Day Treatment Protocol

1

Day 1

Comprehensive Diagnostics

  • Full medical history and inflammation profiling
  • Advanced blood panel and biomarker assessment
  • Body composition and metabolic evaluation
  • Personalized treatment protocol design
2

Day 2

Antioxidant & Detox IV

  • High-dose antioxidant IV (NAC, ALA, Vitamin C)
  • Cellular detoxification preparation
  • Mitochondrial support infusion
  • Body priming for stem cell integration
3

Day 3

50M Stem Cell IV Infusion

  • 50 Million fresh mesenchymal stem cells
  • Systemic anti-inflammatory action
  • Immune pathway rebalancing
  • Tissue repair activation
4

Day 4

NAD+ IV & Recovery

  • High-dose NAD+ for cellular energy
  • Neurological and mitochondrial support
  • Recovery monitoring and assessment
5

Day 5

Follow-Up & Roadmap

  • Post-treatment review and assessment
  • Personalized recovery roadmap
  • 3-month and 6-month follow-up scheduling

所有项目均包含

医疗方案与贵宾服务

每套干细胞项目均包含完整的医疗方案,以及为国际访客提供的礼宾服务。

医疗方案

  • 深度血液诊断分析
  • 临床级外泌体输注,500 亿
  • 个性化细胞静脉输注
  • 代谢与身体成分评估
  • 由医师设计的再生医学路线图

贵宾接待与照护 — 已包含

  • 机场快速通道与专车接送
  • 抵达时贵宾电瓶车与行李搬运
  • 专属医疗礼宾
  • 住院期间专属护士
  • 系统化随访与监测
投资

治疗方案

Chronic Pain & Fatigue Stem Cell Therapy 方案起价

THB 559,000

最终治疗方案和定价在医疗咨询和诊断评估后确定。我们的医生根据您的健康评估、治疗目标和临床需求设计个性化方案。

医生主导

医疗级

持续护理

个性化

剂量与价格

所有价格以泰铢计,为诊所现场结算币种。每套方案在您决定前均已列明细胞剂量。

Systemic protocol aimed at immune rebalancing and inflammation reduction. Same dose and price as the 50 million cell body tier, positioned by indication.

Chronic Pain & Fatigue — 细胞剂量与泰铢价格
剂量价格
50 million cellsTHB 559,000约合 USD 18,000

哪套方案适合您的情况

Widespread pain with no single joint at fault
通常讨论的层级: 50 million cells. Systemic delivery rather than an injection into one site. 最终方案与剂量由医师在临床评估后确定。
Fatigue that persists after a viral illness
通常讨论的层级: 50 million cells. Positioned around immune rebalancing. There is no established cell-based treatment for post-viral fatigue; this is investigational and eligibility is assessed case by case. 最终方案与剂量由医师在临床评估后确定。
Long-standing inflammatory burden on blood markers
通常讨论的层级: 50 million cells. Assessed against blood markers before and after. 最终方案与剂量由医师在临床评估后确定。

All stem cell protocols are investigational; outcomes vary and are not guaranteed. Eligibility and final dose are confirmed by a physician after clinical assessment. Fresh UC-MSC processed in GMP and ISO certified partner laboratories.

Ideal Candidates

Who Is This Program For?

Chronic Pain Sufferers

Individuals with persistent pain unresponsive to conventional treatments.

Persistent Fatigue

Guests experiencing long-standing fatigue, low energy, and widespread discomfort.

Immune Imbalance

Those managing inflammation and immune dysregulation under physician care.

Post-Illness Recovery

Guests seeking cellular support and immune restoration after prolonged illness.

Healthi Life medical team for chronic pain stem cell therapy

Frequently Asked Questions

A physician-led regenerative protocol using 50 million fresh mesenchymal stem cells delivered via IV infusion to calm systemic inflammation, rebalance immune pathways, and promote long-term tissue healing for chronic pain and fatigue conditions.

Individuals living with persistent pain, long-standing fatigue, or inflammation-related conditions that have not responded to conventional care. Suitability is always confirmed by a physician assessment — this protocol is supportive regenerative care, not a cure for any specific disease.

While Body Stem Cell Therapy focuses on anti-aging and whole-body regeneration, this protocol specifically targets chronic pain pathways, immune dysregulation, and inflammatory conditions with a physician-set therapeutic dose of 50 million MSCs.

Fresh — administered without a freeze-thaw cycle, avoiding the transient, largely reversible reduction in viability and immunomodulatory function documented immediately post-thaw (Moll et al., Current Stem Cell Reports, 2022; Bahsoun et al., Journal of Translational Medicine, 2019). Frozen cells remain safe and clinically used; fresh is our protocol choice. Investigational; outcomes vary.

The complete protocol spans 3-5 days, including diagnostics, preparation, stem cell infusion, NAD+ therapy, and follow-up assessment.

Some guests report early anti-inflammatory effects within 1-2 weeks. Progressive changes in pain, energy, and function are reported over 3-6 months; responses vary between individuals and are not guaranteed.

No. The stem cells are administered via standard IV infusion in a comfortable clinical setting. There is no surgery or invasive procedure involved.

Yes. Many guests benefit from combining this protocol with NAD+ maintenance, exosome therapy, or targeted IV nutrition for sustained results.

The Chronic Pain & Fatigue program starts from THB 559,000. Final protocol is determined after medical consultation based on individual condition severity.

Ready to Take On Chronic Pain & Fatigue?

Book your free consultation to discuss your condition with our regenerative medicine specialists.

研究结果说明了什么

间充质干细胞治疗是一个持续开展临床研究的领域。以下是我们制定治疗方案所依据的同行评审研究结果,并列出每项研究的实测数据。

  1. 汇总 36 项研究、1012 名受试者,经血管给予间充质干细胞未见与急性输注毒性、器官系统并发症、感染、死亡或恶性肿瘤相关。但与一过性发热存在显著相关性。

    Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical TrialsPLOS ONE, 2012

  2. 在 12 个月时,重复给予脐带间充质干细胞组的 WOMAC 疼痛评分为 1.1,透明质酸组为 4.3(p = 0.04)。MRI 评分未见差异。

    Umbilical Cord-Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II TrialStem Cells Translational Medicine, 2019

  3. 合并三项随机对照试验,关节内注射脐带间充质干细胞使 WOMAC 指数下降 25.85 分(p = 0.001),Lysholm 膝关节评分提高 18.33 分(p < 0.00001)。

    Effects of the umbilical cord mesenchymal stem cells in the treatment of knee osteoarthritis: A systematic review and meta-analysisMedicine (Baltimore), 2024

  4. 在骨关节炎的随机对照试验中,间充质干细胞治疗组与对照组的治疗相关不良事件无显著差异。

    Relative efficacy and safety of mesenchymal stem cells for osteoarthritis: a systematic review and meta-analysis of randomized controlled trialsFrontiers in Endocrinology, 2024

  5. 干细胞分泌抗炎因子、细胞因子和外泌体,抑制炎症反应并改善受损区域的微环境,进而调控细胞增殖与分化。

    Enhancing regenerative medicine: the crucial role of stem cell therapyFrontiers in Neuroscience, 2024

这些研究描述的是其各自试验人群中观察到的结果,不能用于预测您的治疗效果,也不构成任何疗效保证。Healthi Life 的干细胞治疗须经医生面诊和个体医学评估后方可进行。

Medically reviewed by Dr. Petch & Dr. First

Dr. Petch — International Board of Lifestyle Medicine (IBLM) — Diplomate

Dr. First — Dermatologist & Peptides Specialist

Last reviewed: July 1, 2026

本页仅供一般信息参考,不构成医疗建议、诊断或治疗。个体结果存在差异。 针对chronic pain的干细胞治疗仍处于研究阶段,并非已获批准的标准疗法。是否适用及可能的获益,须经医生评估后确定。 请务必就您的健康状况咨询合格医生。请参阅我们的 完整医疗免责声明.